A survey of methicillin-resistant Staphylococcus aureus (MRSA) management in hospices/palliative care units

Pauline Dand1, Joan Fyvie, Alethea Yee

  • 1St Christopher's Hospice, London. paulinednd@aol.com

Palliative Medicine
|June 1, 2005
PubMed

Insights

Most palliative care units have methicillin-resistant Staphylococcus aureus (MRSA) protocols, but staff training is lacking. Screening and consistent infection control measures for MRSA are not widely implemented.

Area of Science:

  • Infectious Diseases
  • Palliative Care Medicine
  • Healthcare Management

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant healthcare challenge.
  • Palliative care units require specific protocols for managing infections like MRSA.
  • Understanding current MRSA management practices in these settings is crucial.

Purpose of the Study:

  • To survey MRSA management protocols in specialist palliative care in-patient units in southern England.
  • To assess the implementation and adherence to these protocols.
  • To identify gaps in MRSA management and staff training.

Main Methods:

  • A questionnaire-based survey was distributed to 63 specialist palliative care in-patient units.
  • An 87% response rate was achieved, providing data on MRSA management practices.
  • Data analysis focused on protocol availability, staff training, screening, isolation, and eradication strategies.

Main Results:

  • 95% of units had MRSA management protocols, but only 59% provided staff training.
  • MRSA screening was performed by 13% of units.
  • Infection control precautions, including isolation (86%) and activity restriction (46%), varied significantly.
  • 41% of respondents questioned the relevance of eradication protocols in hospices.

Conclusions:

  • While most palliative care units have MRSA protocols, significant gaps exist in staff training and consistent implementation of infection control measures.
  • The effectiveness and relevance of MRSA eradication protocols in hospice settings require further consideration.
  • The impact of MRSA on the quality of life and morbidity in palliative care patients remains an understudied area.

Related Concept Videos

Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Documentation in Long-Term and Home Healthcare Setting01:29

Documentation in Long-Term and Home Healthcare Setting

Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...